GOLDWIND (02208) announced that Goldwind Science & Technology Co., Ltd. (the "Company") had previously approved the "General Authorization for Domestic and Overseas Bond and Asset-Backed Securities Issuance" at its 8th Board of Directors' 10th meeting and 2022 Annual General Meeting, as well as the 8th Board of Directors' 31st meeting and 2024 Annual General Meeting. Based on shareholder authorization, the Company's 8th Board of Directors' 33rd meeting held on May 30, 2025, approved the "Proposal on Application for Registration and Issuance of Long-term Medium-term Notes with Embedded Options," agreeing to apply to the China Interbank Market Dealers Association for registration to issue long-term medium-term notes with embedded options totaling no more than RMB 3 billion.

On September 11, 2025, the Company received the "Registration Acceptance Notice" (Document No. NAFMII [2025] MTN878) from the China Interbank Market Dealers Association, agreeing to accept the Company's medium-term note registration with a registration amount of RMB 3 billion. The registration quota is valid for 2 years from the date of the Registration Acceptance Notice. The joint lead underwriters include Bank of China Limited, Industrial Bank Co., Ltd., Bank of Communications Co., Ltd., China CITIC Bank Corporation Limited, China Merchants Bank Co., Ltd., and Ping An Bank Co., Ltd.

The Company may issue medium-term notes in tranches within the registration validity period. Upon completion of issuance, the results should be disclosed through channels recognized by the Dealers Association. The Company will handle matters related to the issuance of these medium-term notes within the specified validity period according to the requirements of the Registration Acceptance Notice and in compliance with the "Registration and Issuance Rules for Non-financial Enterprise Debt Financing Instruments," "Registration Working Procedures for Non-financial Enterprise Debt Financing Instruments," "Information Disclosure Rules for Non-financial Enterprise Debt Financing Instruments," and other relevant regulatory guidelines, while fulfilling information disclosure obligations in a timely manner.